Future-Proofing Your CMC Strategy: Managing Critical Starting Material Changes

Changing a critical starting material, whether driven by supply chain risk, a new supplier, process improvement or obsolescence, can have significant implications for analytical comparability, stability, regulatory strategy and development timelines.

In this on-demand webinar, Sandeep Yadav, PhD, Principal at SY Biopharma Consulting, explores the key considerations involved in preparing a regulatory submission to support a critical starting material change. Drawing on real-world experience, he discusses how to build a scientifically sound, risk-based justification that addresses regulatory expectations while keeping development programmes on track.

What you’ll learn in this webinar

  • How to define and justify a critical starting material, and how its classification can shape CMC strategy and regulatory pathways

  • What regulators expect from comparability data, risk assessments and the scientific evidence supporting a critical starting material change

  • How to structure an effective CMC submission and communicate proactively with regulatory agencies

  • Key considerations when navigating differing expectations across agencies, including the FDA and EMA

  • How to plan for implementation and manage timelines when starting material changes are unavoidable or urgent

Navigating critical starting material changes with a risk-based CMC strategy

Changes to critical starting materials can affect multiple aspects of a development programme, from manufacturing and analytical comparability to stability and regulatory submissions. A well-planned CMC strategy can help teams assess the potential impact of a change, generate appropriate supporting evidence and establish a clear scientific rationale.

This webinar provides practical considerations for approaching these changes throughout development and preparing the evidence needed to support regulatory interactions and submissions.

Who should watch

  • CMC and Regulatory Affairs professionals

  • Process Development and Manufacturing scientists

  • Analytical Development and Quality professionals

  • Technical and Project leaders responsible for CMC strategy, process changes and lifecycle management

Next
Next

Sequence to Solution: Synthetic DNA Accelerating Advanced Therapies